These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 28333072)
1. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493 [TBL] [Abstract][Full Text] [Related]
4. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH. Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145 [TBL] [Abstract][Full Text] [Related]
5. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells. Ge F; Zhang H; Wang DD; Li L; Lin PP Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323 [TBL] [Abstract][Full Text] [Related]
6. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells. Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533 [TBL] [Abstract][Full Text] [Related]
7. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer. Chen Y; Yang Z; Wang Y; Wang J; Wang C BMC Cancer; 2019 Jul; 19(1):651. PubMed ID: 31269908 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer. Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma. Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007 [TBL] [Abstract][Full Text] [Related]
10. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization]. Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292 [No Abstract] [Full Text] [Related]
11. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196 [TBL] [Abstract][Full Text] [Related]
12. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer. Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744 [TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer. Qiu ZL; Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Zhang GQ; Chen XY; Luo QY Cell Physiol Biochem; 2018; 48(2):718-730. PubMed ID: 30025398 [TBL] [Abstract][Full Text] [Related]
15. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies. Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application. Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872 [TBL] [Abstract][Full Text] [Related]
17. Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer. Zhang J; Hong Y; Wang L; Hu W; Tian G; Wu D; Wang Y; Dai L; Zhang Z; Yang Y; Fang J Front Oncol; 2023; 13():829054. PubMed ID: 37213309 [TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma. Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380 [TBL] [Abstract][Full Text] [Related]
19. Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy. Ren C; Han C; Zhang J; He P; Wang D; Wang B; Zhao P; Zhao X Cancer Biol Ther; 2011 Oct; 12(8):700-6. PubMed ID: 21811100 [TBL] [Abstract][Full Text] [Related]
20. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer. Chen YY; Xu GB Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]